ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosengart, T. K.
Right arrow Articles by Isom, O. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosengart, T. K.
Right arrow Articles by Isom, O. W.

The Annals of Thoracic Surgery, Vol 58, 1397-1403, Copyright © 1994 by The Society of Thoracic Surgeons

ARTICLES

Combined aprotinin and erythropoietin use for blood conservation: results with Jehovah's Witnesses

TK Rosengart, RE Helm, J Klemperer, KH Krieger and OW Isom
Department of Cardiothoracic Surgery, New York Hospital-Cornell University Medical Center, New York 10021.

Despite recent advances in blood conservation techniques, major risks persist for excessive bleeding and blood transfusion after open heart operations. We reviewed the records of 100 consecutive patients undergoing first-time coronary artery bypass grafting at our institution to define these risks and develop a multimodality blood conservation program based on the results. This program was subsequently applied on a prospective basis to a select group of patients who refuse blood transfusion on religious grounds (Jehovah's Witnesses [JW]) (n = 15). Encouraging initial results with coronary artery bypass grafting in this group (n = 8) led to the application of the program to more complex operations (n = 7), including repeat bypass grafting with use of the internal mammary artery, repeat mitral valve replacement, aortic and mitral valve replacement with coronary artery bypass grafting, mitral valve replacement with bypass grafting, chronic type 1 dissection repair, aortic valve replacement, and atrial septal defect repair in 1 patient each. The blood conservation program employed in these patients included the use of (1) aprotinin (full Hammersmith regimen), (2) high-dose erythropoietin, (3) "maximal"- volume intraoperative autologous blood donation, (4) low-prime cardiopulmonary bypass, (5) exclusive use of intraoperative cell salvage, and (6) continuous reinfusion of shed mediastinal blood. There were no deaths in the JW group. Thromboembolic complications consisted of a transient posterior circulation stroke in only 1 patient (dissection repair). No blood or blood products were transfused compared with the transfusion of 5.1 +/- 7.8 units (mean +/- standard deviation) in the 100 primary coronary bypass patients in whom the blood conservation program was not employed.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
R. Sniecinski and J. H. Levy
What Is Blood and What Is Not? Caring for the Jehovah's Witness Patient Undergoing Cardiac Surgery
Anesth. Analg., April 1, 2007; 104(4): 753 - 754.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
L. Engles
Review and application of serine protease inhibition in coronary artery bypass graft surgery
Am. J. Health Syst. Pharm., September 15, 2005; 62(18_Supplement_4): S9 - S14.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. L. Holt, T. D. Martin, P. J. Hess, T. M. Beaver, and C. T. Klodell
Jehovah's witnesses requiring complex urgent cardiothoracic surgery
Ann. Thorac. Surg., August 1, 2004; 78(2): 695 - 697.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. Pajoumand, B. L Erstad, and J. M Camamo
Use of Epoetin Alfa in Critically Ill Patients
Ann. Pharmacother., April 1, 2004; 38(4): 641 - 648.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2003; 2(2003): 389 - 400.
[Full Text]

Home page
 PerfusionHome page
R. C Groom
High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question
Perfusion, March 1, 2002; 17(2): 99 - 102.
[PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
L. YazicioGlu, S. Eryilmaz, M. Sirlak, M. B. Inan, A. Aral, R. Tasoz, N. T. Eren, B. Kaya, and H. Akalin
Recombinant human erythropoietin administration in cardiac surgery
J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 741 - 745.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
R. C Groom
High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question
Perfusion, September 1, 2001; 16(5): 339 - 343.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
D. M. McMullan, E. A.K. Beyer, I. Gregoric, B. Radovancevic, and O.H. Frazier
Left ventricular reduction in a Jehovah's Witness
Ann. Thorac. Surg., September 1, 2000; 70(3): 958 - 960.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. K. Rosengart, W. DeBois, M. O'Hara, R. Helm, M. Gomez, S. J. Lang, N. Altorki, W. Ko, G. S. Hartman, O. W. Isom, et al.
Retrograde Autologous Priming For Cardiopulmonary Bypass: A Safe And Effective Means Of Decreasing Hemodilution And Transfusion Requirements
J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 426 - 439.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. E. Helm, T. K. Rosengart, M. Gomez, J. D. Klemperer, W. J. DeBois CPP, F. Velasco, J. P. Gold, N. K. Altorki, S. Lang, S. Thomas, et al.
Comprehensive Multimodality Blood Conservation: 100 Consecutive CABG Operations Without Transfusion
Ann. Thorac. Surg., January 1, 1998; 65(1): 125 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. K. Rosengart, KarlH. Krieger, and J. A. Magovern
Predicting Transfusion
Ann. Thorac. Surg., December 1, 1996; 62(6): 1885 - 1886.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
R. E. Helm, J. D. Klemperer, T. K. Rosengart, J. P. Gold, P. Peterson, W. DeBois, N. K. Altorki, S. Lang, S. Thomas, O. W. Isom, et al.
Intraoperative Autologous Blood Donation Preserves Red Cell Mass But Does Not Decrease Postoperative Bleeding
Ann. Thorac. Surg., November 1, 1996; 62(5): 1431 - 1441.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.